Merit Medical Systems, Inc. (NASDAQ:MMSI) has earned an average recommendation of “Buy” from the ten brokerages that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $36.71.

A number of research firms recently commented on MMSI. Sidoti restated a “buy” rating and issued a $46.00 price objective (up previously from $41.00) on shares of Merit Medical Systems in a research report on Wednesday, June 28th. BidaskClub upgraded shares of Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, June 27th. Piper Jaffray Companies restated an “overweight” rating and issued a $39.00 price objective on shares of Merit Medical Systems in a research report on Monday, June 26th. Zacks Investment Research upgraded Merit Medical Systems from a “hold” rating to a “buy” rating and set a $41.00 target price for the company in a report on Thursday, June 22nd. Finally, SunTrust Banks, Inc. started coverage on Merit Medical Systems in a report on Tuesday, June 20th. They set a “buy” rating and a $43.00 target price for the company.

Shares of Merit Medical Systems (NASDAQ MMSI) traded down 1.07% during mid-day trading on Tuesday, hitting $37.15. The stock had a trading volume of 482,099 shares. The stock has a market capitalization of $1.85 billion, a price-to-earnings ratio of 55.20 and a beta of 1.24. The stock’s 50-day moving average price is $36.73 and its 200-day moving average price is $31.29. Merit Medical Systems has a 12-month low of $20.70 and a 12-month high of $38.55.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Thursday, April 27th. The medical instruments supplier reported $0.28 EPS for the quarter, beating the Zacks’ consensus estimate of $0.23 by $0.05. Merit Medical Systems had a net margin of 4.80% and a return on equity of 9.36%. The business had revenue of $171.07 million during the quarter, compared to analysts’ expectations of $163.50 million. During the same quarter in the prior year, the company earned $0.19 EPS. The firm’s quarterly revenue was up 23.9% on a year-over-year basis. On average, equities analysts anticipate that Merit Medical Systems will post $1.17 EPS for the current fiscal year.

In other news, insider Richard W. Edelman sold 20,000 shares of the stock in a transaction dated Friday, June 30th. The shares were sold at an average price of $37.62, for a total transaction of $752,400.00. Following the completion of the transaction, the insider now directly owns 35,000 shares in the company, valued at approximately $1,316,700. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director F. Ann Millner sold 6,744 shares of the stock in a transaction dated Wednesday, June 28th. The stock was sold at an average price of $38.15, for a total transaction of $257,283.60. Following the transaction, the director now owns 4,247 shares of the company’s stock, valued at $162,023.05. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 82,944 shares of company stock valued at $2,944,127. Company insiders own 5.60% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. BlackRock Inc. increased its position in Merit Medical Systems by 7,837.9% in the first quarter. BlackRock Inc. now owns 6,789,527 shares of the medical instruments supplier’s stock worth $196,218,000 after buying an additional 6,703,994 shares in the last quarter. Vanguard Group Inc. increased its position in Merit Medical Systems by 16.1% in the first quarter. Vanguard Group Inc. now owns 4,186,883 shares of the medical instruments supplier’s stock worth $121,001,000 after buying an additional 580,871 shares in the last quarter. Frontier Capital Management Co. LLC increased its position in Merit Medical Systems by 14.3% in the first quarter. Frontier Capital Management Co. LLC now owns 2,193,723 shares of the medical instruments supplier’s stock worth $63,399,000 after buying an additional 274,150 shares in the last quarter. Ameriprise Financial Inc. increased its position in Merit Medical Systems by 11.8% in the first quarter. Ameriprise Financial Inc. now owns 1,677,925 shares of the medical instruments supplier’s stock worth $48,491,000 after buying an additional 177,548 shares in the last quarter. Finally, State Street Corp increased its position in Merit Medical Systems by 1.7% in the first quarter. State Street Corp now owns 1,218,788 shares of the medical instruments supplier’s stock worth $35,223,000 after buying an additional 20,885 shares in the last quarter. Institutional investors own 90.60% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://www.americanbankingnews.com/2017/07/18/merit-medical-systems-inc-mmsi-receives-consensus-rating-of-buy-from-analysts.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Analyst Recommendations for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.